Technical analysis of Humacyte, Inc. (HUMA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs).
Price Performance
| 1 month | -2.01% |
| 3 months | -38.34% |
| Year-to-date | -40.66% |
| 1 year | -62.75% |
| 3 years | -81.31% |
| 5 years | -96.01% |
52-Week Range
| 52-week High | $2.55 |
| 52-week Low | $0.53 |
| Avg Volume (90d) | 9.7M |
Technical Indicators
| SMA 50 | $0.65 |
| SMA 200 | $0.92 |
| Beta | 2.10 |
| 30-day Volatility (annualised) | 111.1% |
| Price vs SMA 50 | -12.0% |
| Price vs SMA 200 | -37.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.67 | |
| 2025-11 | $1.35 | -19.2% |
| 2025-12 | $0.96 | -28.9% |
| 2026-01 | $1.00 | +3.9% |
| 2026-02 | $1.12 | +12.3% |
| 2026-03 | $0.61 | -45.8% |
| 2026-04 | $0.84 | +38.8% |
| 2026-05 | $1.30 | +54.4% |
| 2026-06 | $0.78 | -40.0% |
| 2026-07 | $0.65 | -16.3% |
| 2026-08 | $0.60 | -8.0% |
| 2026-09 | $0.57 | -5.2% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.57 |
| Market Cap | $96M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.30 |
| EV / EBITDA | -1.10 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 2.12 |
| Current Ratio | 6.21 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -10.46 |